SEC Filings - Keros Therapeutics

Filing Date	Form	Description	View
Nov 21, 2018	D		0001664710-18-000001.pdf 0001664710-18-000001.rtf View HTML
Mar 12, 2020	D		0001664710-20-000001.pdf 0001664710-20-000001.rtf 0001664710-20-000001.xls View HTML
Apr 29, 2016	D		0001664710-16-000001.pdf 0001664710-16-000001.rtf 0001664710-16-000001.xls View HTML
Aug 18, 2016	D/A		0001664710-16-000002.pdf 0001664710-16-000002.rtf 0001664710-16-000002.xls View HTML
Nov 13, 2017	D/A		0001664710-17-000002.pdf 0001664710-17-000002.rtf 0001664710-17-000002.xls View HTML
Apr 15, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-20-046925.pdf 0001104659-20-046925.rtf 0001104659-20-046925.xls View HTML
Aug 31, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000935836-20-000488.pdf 0000935836-20-000488.rtf 0000935836-20-000488.xls View HTML
Nov 10, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000315066-20-001907.pdf 0000315066-20-001907.rtf View HTML
Feb 02, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000834237-21-007043.pdf 0000834237-21-007043.rtf View HTML
Feb 10, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-019848.pdf 0001104659-21-019848.rtf 0001104659-21-019848.xls View HTML

Data provided by Kaleidoscope.

Investor Contact